Role of Endothelial Nitric Oxide Synthase (T786C) Gene Polymorphism in the Development of Coronary Artery Disease.

WHO Cardiovascular diseases (CVDs). World Health Organization; [cited 2015 Apr 19]. http://www.who.int/mediacentre/factsheets/fs317/en/            

What Are Coronary Heart Disease Risk Factors? - NHLBI, NIH [cited 2015 Apr 20]. https://www.nhlbi.nih.gov/health/health-topics/topics/hd

Goyal A, Yusuf S. The burden of cardiovascular disease in the Indian subcontinent. Indian J Med Res 2006;124(3):235-44.        

Hadi HA, Al Suwaidi. Endothelial dysfunction in diabetes mellitus. Vasc Health Risk Manag 2007;3(6):853-76.            

Ray S, Bairagi AK, Guha S, et al. A simple way to identify insulin resistance in non-diabetic acute coronary syndrome patients with impaired fasting glucose. Indian J Endocrinol Metab 2012;16(Suppl 2):S460-4.          

Vecoli C, Andreassi MG, Liga R, et al. T(-786)→C polymorphism of the endothelial nitric oxide synthase gene is associated with insulin resistance in patients with ischemic or non ischemic cardiomyopathy. BMC Med Genet 2012;13(1):92.   

Samant P, Chavan P, Rai S. Association of eNOS gene variant with insulin resistance in Metabolic Syndrome Material & Methods 2014;2(6):784-91.

Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3(11):e442.            

WHO. The global burden of disease: 2004 update. World Health Organization; [cited 2015 Apr 28]. http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/

Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009;119(3):e21-81.             

Coronary artery disease management: to relieve symptoms and reduce the risk of cardiovascular events | CLARIFY registry official web site [cited 2015 Apr 28]. http://www.clarify-registry.com/journalists/about-coronary-artery-disease/4-coronary-artery-disease-management/

World Health Organization. a Vital Investment. World Health, 2005: p. 202.

World Health Organization. a Vital Investment. World Health, 2005: p. 202.

Beaglehole R, Bonita R. Global public health: a scorecard. Lancet 2008;372(9654):1988-96.                                

WHO. Burden of disease: DALYs. Glob Burd Dis 2004 Updat. 2008: p. 40–51.

Jones DW, Chambless LE, Folsom AR, et al. Risk factors for coronary heart disease in african americans: The Atherosclerosis Risk in Communities Study, 1987-1997. Arch Intern Med 2002;162(22):2565-71.               

Tendera M. How much does Europe invest in the treatment of cardiovascular diseases? Eur Heart J 2006;27(13):1521-2.                   

Yoshimura T, Hisatomi A, Kajihara S, et al. The relationship between insulin resistance and polymorphisms of the endothelial nitric oxide synthase gene in patients with coronary artery disease. J Atheroscler Thromb 2003;10(1):43-7.         

Fox KA. Implications of the organization to assess strategies for ischemic syndromes-2 (OASIS-2) study and the results in the context of other trials. Am J Cardio 1999;84(5A):26M-31M.               

Mohan V, Venkatraman JV, Pradeepa R. Epidemiology of cardiovascular disease in type 2 diabetes: the Indian scenario. J Diabetes Sci Technol 2010;4(1):158-70.              

Okita K, Iwahashi H, Kozawa J, et al. Homeostasis model assessment of insulin resistance for evaluating insulin sensitivity in patients with type 2 diabetes on insulin therapy. Endocr J 2013;60(3):283-90.               

Kontos MC, Diercks DB, Kirk JD. Emergency department and office-based evaluation of patients with chest pain. Mayo Clin Proc 2010;85(3):284-99.          

Lee IM, Shiroma EJ, Lobelo F, et al. Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet 2012;380(9838):219-29.             

Kivimäki M, Nyberg ST, Batty GD, et al. Job strain as a risk factor for coronary heart disease: a collaborative meta-analysis of individual participant data. Lancet 2012;380(9852):1491-7.                              

Wang HX, Leineweber C, Kirkeeide R, et al. Psychosocial stress and atherosclerosis: family and work stress accelerate progression of coronary disease in women. The Stockholm Female Coronary Angiography Study J Intern Med 2007;261(3):245-54.